Pricing
InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.
Industries
Headquarters
Employees
Links
Full screen
Niels C. Riedemann
View all
7 people · 0 jobs
5 people · 0 jobs
4 people · 0 jobs
3 people · 0 jobs
HQ
1 person · 0 jobs
BioNTech
33 followers
Tango Therapeutics
3 followers
Cellares
4 followers
Sanofi
293 followers
Gilead Sciences
161 followers
Regeneron
133 followers
Illumina
79 followers
Agilent Technologies
85 followers
Lonza
71 followers
Verily Life Sciences
45 followers
Alexion Pharmaceuticals
Explore companies